Long-Term (≥5-Year) Remission and Survival After Treatment With Ciltacabtagene Autoleucel in CARTITUDE-1 Patients With Relapsed/Refractory Multiple MyelomaSundar Jagannath, Peter M. Voorhees, Saad Z. Usmani et al.|Journal of Clinical Oncology|2025Cited by 107